Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is an established risk factor for diabetes, cardiovascular disease, antiviral treatment resistance, and progression of chronic hepatitis C virus (HCV) infection to fibrosis. Apolipoprotein-B 100 (ApoB-100) is a dyslipidemia marker and steatosis pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ming-Shyan, Guo, Su-Er, Lin, Huang-Shen, Hsu, Jen-Te, Lin, Yu-Sheng, Lin, Tsai-Hui, Huang, Tung-Jung, Chen, Mei-Yen, Chung, Chang-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger GmbH 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644880/
https://www.ncbi.nlm.nih.gov/pubmed/27054361
http://dx.doi.org/10.1159/000443692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644880/
https://www.ncbi.nlm.nih.gov/pubmed/27054361
http://dx.doi.org/10.1159/000443692

Ejemplares similares